CM
CME
Quarter ended Mar 31, 2024 · FY2024 Q1

CME Group (CME) Revenue — Quarter Ended Mar 31, 2024

Revenue for the current quarter increased compared to the prior quarter. It also rose versus the same quarter last year.

Key takeaway

Quarter ended Mar 31, 2024 · FY2024 Q1

Revenue for the current quarter increased compared to the prior quarter. It also rose versus the same quarter last year.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$1.5B

Revenue reported for this quarter.

Quarter-over-quarter

+3.4%

Change from the immediately preceding quarter.

Year-over-year

+3.2%

Change from the comparable year-ago quarter.

Trailing four quarters

$5.6B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Jun 30, 2023$1.4B+9.9%
Sep 30, 2023$1.3B+9.0%
Dec 31, 2023$1.4B+19.2%
Mar 31, 2024$1.5B+3.2%

Revenue performance

Reported revenue moved higher for the quarter. The trailing twelve-month revenue remained at an elevated level.

Quarterly comparison

Revenue increased compared to the immediately preceding quarter. It also grew when measured against the same quarter one year earlier.

What to watch

The filing notes flat cash from operations year-over-year but higher financing cash flows from increased performance bonds and guaranty fund contributions.